First-in-Human Study of the CD123 NK Cell Engager SAR443579 in Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia or High Risk-Myelodysplasia: Updated Safety, Efficacy, Pharmacokinetics and Pharmacodynamics
Ashish Bajel,Sylvain Garciaz,Pinkal Desai,Gerwin Huls,Abhishek Maiti,Mojca Jongen‐Lavrencic,Nicolas Boissel,Stéphane de Botton,David C. de Leeuw,Shaun Fleming,C. Michel Zwaan,Martha Arellano,David Avigan,Jennifer N. Saultz,Ioannis Mantzaris,Kyle Jensen,Timothy R. Wagenaar,Gu Mi,Samira Ziti‐Ljajic,Dobrin Draganov
出处
期刊:Blood [American Society of Hematology] 日期:2023-11-02卷期号:142 (Supplement 1): 3474-3474被引量:8